Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (141-150 of 825) with videos related to

Pageof 83
Sort By:
Progress in Clinical and Biological Research|January 1, 1988
Chemotherapy for advanced urothelial tract tumors: the M-VAC regimenC N Sternberg, A Yagoda, H I Scher
Current Pain and Headache Reports|November 5, 2002
Risk factors for chronic daily headacheAnn I Scher, Richard B Lipton, Walter Stewart
Urology|August 1, 1995
Hormone-refractory (D3) prostate cancer: refining the conceptH I Scher, G Steineck, W K Kelly
Annals of the New York Academy of Sciences|January 1, 1982
IgD as a receptor in signaling the proliferation of mouse B-lymphocytesD G Sieckmann, F D Finkelman, I Scher
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1976
In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharideD E Mosier, I Scher, W E Paul
Urology|August 1, 1990
Transrectal sonography for serial evaluation of prostatic malignancyD D Dershaw, H I Scher, T Smart
Seminars in Oncology|December 1, 1996
Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancerW K Kelly, S Slovin, H I Scher
Headache|January 19, 2024
Author Response to Comment on "Plasma calcitonin gene-related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion"Ann I Scher, Xiyun Chai, Kirk W Johnson
Clinical and Experimental Immunology|March 1, 1976
Selective inhibition of lymphocyte responsiveness to phytohaemagglutinin in patients with Reiter's syndromeI Scher, A Ahmed, D M Strong, et al.
Seminars in Urologic Oncology|March 21, 1998
Immunological approaches for the treatment of prostate cancerS F Slovin, W K Kelly, H I Scher
Pageof 83

Showing results (141-150 of 825) with videos related to

Sort By:
Pageof 83
Progress in Clinical and Biological Research|January 1, 1988
Chemotherapy for advanced urothelial tract tumors: the M-VAC regimenC N Sternberg, A Yagoda, H I Scher
Current Pain and Headache Reports|November 5, 2002
Risk factors for chronic daily headacheAnn I Scher, Richard B Lipton, Walter Stewart
Urology|August 1, 1995
Hormone-refractory (D3) prostate cancer: refining the conceptH I Scher, G Steineck, W K Kelly
Annals of the New York Academy of Sciences|January 1, 1982
IgD as a receptor in signaling the proliferation of mouse B-lymphocytesD G Sieckmann, F D Finkelman, I Scher
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1976
In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharideD E Mosier, I Scher, W E Paul
Urology|August 1, 1990
Transrectal sonography for serial evaluation of prostatic malignancyD D Dershaw, H I Scher, T Smart
Seminars in Oncology|December 1, 1996
Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancerW K Kelly, S Slovin, H I Scher
Headache|January 19, 2024
Author Response to Comment on "Plasma calcitonin gene-related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion"Ann I Scher, Xiyun Chai, Kirk W Johnson
Clinical and Experimental Immunology|March 1, 1976
Selective inhibition of lymphocyte responsiveness to phytohaemagglutinin in patients with Reiter's syndromeI Scher, A Ahmed, D M Strong, et al.
Seminars in Urologic Oncology|March 21, 1998
Immunological approaches for the treatment of prostate cancerS F Slovin, W K Kelly, H I Scher
Pageof 83